Nature Medicine, Published online: 21 October 2026; doi:10.1038/s41591-026-04747-2
Author Correction: Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials
Science News
Nature Medicine, Published online: 21 October 2026; doi:10.1038/s41591-026-04747-2
Author Correction: Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials
